Assignee
ONCOC4 INC
US·7 granted patents·8 pending applications·8 citations·filing 2017–2025
Top patents by PatentIndex Score
15 records- 0193US12227557B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Feb 18, 2025·2 cites·20 claims
- 0286US11261233B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2017·Granted Mar 1, 2022·6 cites·19 claims
- 0379US12473362B2Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereofONCOC4 INC·Filed 2023·Granted Nov 18, 2025·0 cites·12 claims
- 0476US12441780B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 0574US2025043003A1Mutant anti-ctla-4 antibodies with improved immunotherapeutic effect but attenuated adverse effectsONCOC4 INC·Filed 2024·Application pending·0 cites
- 0667US11629188B2Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereofONCOC4 INC·Filed 2020·Granted Apr 18, 2023·0 cites·12 claims
- 0766US2026092112A1Use of anti-ctla-4 antibodies for treating adenoid cystic carcinomaONCOC4 INC·Filed 2023·Application pending·0 cites
- 0863US12129299B2Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effectsONCOC4 INC·Filed 2019·Granted Oct 29, 2024·0 cites·6 claims
- 0963US2025333532A1Glycan-shielded cd24 epitopes and uses thereofONCOC4 INC·Filed 2025·Application pending·0 cites
- 1063US2025243292A1Anti-cd24 compositions and uses thereofONCOC4 INC·Filed 2025·Application pending·0 cites
- 1158US12286485B2Anti-CD24 compositions and uses thereofONCOC4 INC·Filed 2019·Granted Apr 29, 2025·0 cites·13 claims
- 1258US2024139280A1Use of hif-1-alpha inhibitors in cancer immunotherapyONCOC4 INC·Filed 2022·Application pending·0 cites
- 1358US2025387493A1Method of abrogating anti-drug antibody formation, and drug conjugates for use thereinONCOC4 INC·Filed 2025·Application pending·0 cites
- 1458US2024218067A1Anti-siglec compositions and uses thereofONCOC4 INC·Filed 2022·Application pending·0 cites
- 1557US2025257117A1Mutant cd24 proteins and uses thereof for prophylaxis and treatment of cancerONCOC4 INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCOC4 INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →